Search

Displaying results 6531 - 6540 of 10000 in total
  1. Drug

    Lanimostim

    go.drugbank.com/drugs/DB06559
    Experimental

  2. Drug

    Vipadenant

    go.drugbank.com/drugs/DB06625
    Investigational

  3. Drug

    Zibotentan

    go.drugbank.com/drugs/DB06629
    Investigational

  4. Drug

    Cantuzumab ravtansine

    go.drugbank.com/drugs/DB05594
    Investigational

  5. Drug

    OTI-030

    go.drugbank.com/drugs/DB05648
    Investigational

  6. Drug

    Iodofiltic acid I-123

    go.drugbank.com/drugs/DB05683
    Investigational

    Synonyms: I-123 BMIPP, Iodofiltic acid I 123
  7. Drug

    R-1487

    go.drugbank.com/drugs/DB06518
    Experimental

  8. Drug

    Butaperazine

    go.drugbank.com/drugs/DB13213
    Approved

    Butaperazine was approved in 1967 [L5143], and possibly discontinued in the 1980s [T397].

  9. Drug

    Seliciclib

    go.drugbank.com/drugs/DB06195
    Investigational

    R-roscovitine (Seliciclib or CYC202) is a cyclin-dependent kinase (CDK) inhibitor that preferentially inhibits multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase of treated … Developed by Cyclacel, seliciclib is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex infection, and the mechanisms of chronic inflammation

  10. Drug

    Sitimagene ceradenovec

    go.drugbank.com/drugs/DB04907
    Experimental

    Sitimagene ceradenovec is a novel gene-based product for the treatment of patients with operable high grade glioma, a type of malignant brain tumour, given in addition to standard surgery and radiotherapy … It is being developed by Ark Therapeutics.